Navigation Links
3SBio Inc. to Present at the UBS Greater China Conference 2012
Date:1/9/2012

SHENYANG, China, Jan. 9, 2012 /PRNewswire-Asia-FirstCall/ -- 3SBio Inc. (NASDAQ: SSRX) ("3SBio" or "the Company"), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced Mr. Bo Tan, 3SBio's chief financial officer will attend the UBS Greater China Conference 2012 in Shanghai on January 11, 2012. A copy of Mr. Tan's presentation will be archived at www.3sbio.com under the investor relations section.  

About 3SBio Inc.

3SBio is a leading, fully integrated, profitable biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products primarily in China.  Its focus is on addressing large markets with significant unmet medical needs in nephrology, oncology, supportive cancer care, inflammation and infectious diseases.  With headquarters and MP-certified manufacturing facilities in Shenyang, PRC, 3SBio employs over 800 people. Shares trade in the form of American Depositary Shares (ADSs) on the NASDAQ stock market under the ticker symbol "SSRX". Please see www.3SBio.com for more information.

Investor Contacts


Bo Tan
Chief Financial Officer
3SBio Inc.
Tel: + 86 24 2581-1820
ir@3SBio.com

Tom Folinsbee
Director of Investor Relations
3SBio Inc.
Tel: + 852 8191-6991
ir@3SBio.com


'/>"/>
SOURCE 3SBio Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. 3SBio Inc. Announces Results of 2011 Annual General Meeting
2. 3SBio Inc. Announces Unaudited First Quarter 2011 Results
3. 3SBio Inc. Schedules Unaudited First Quarter 2011 Results
4. 3SBio Inc. Schedules Unaudited Fourth Quarter and Fiscal Year 2010 Results
5. 3SBio Inc. Receives SFDA Approval for TPIAO Label Extension for the Treatment of ITP
6. 3SBio Inc. Announces Unaudited Third Quarter Results
7. 3SBio Inc. Announces Unaudited Second Quarter Results
8. 3SBio Inc. Schedules Second Quarter 2010 Unaudited Financial Results
9. 3SBio Inc. Announces Filing of Form 20-F With SEC
10. 3SBio Inc. To Report 2010 First Quarter Unaudited Financial Results on May 16, 2010
11. 3SBio Announces Changes to its Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/19/2019)... NEWPORT BEACH, Calif. (PRWEB) , ... July 18, ... ... who is also known as “Ravi Everest,” will be joining forces with California-based ... to be held from July 20-22nd. Coalition Duchenne raises awareness and funding for ...
(Date:7/9/2019)... ... July 08, 2019 , ... Today, at the ... National Corn Growers Association (NCGA) announced the winners of the Consider Corn ... product or process using field corn to produce biobased materials. , “Corn is a ...
(Date:6/18/2019)... (PRWEB) , ... June 18, 2019 , ... Personalized ... Investigational New Drug (IND) application to the FDA for use of a person’s own ... as a treatment of osteoarthritis in the knee. This IND is the first ...
(Date:6/11/2019)... ... June 11, 2019 , ... Mytonomy, the leader in ... in opioid treatment, announced today they are partnering to combat the opioid crisis ... its virtual care platform at the Mayo Clinic to drive shared decision making ...
Breaking Biology Technology:
(Date:6/18/2019)... , ... June 18, 2019 , ... ... learning cloud solutions, today introduced Data Science Workstations-as-a-Service as part of its dedicated, ... from BOXX Technologies, Cirrascale Data Science Workstations feature NVIDIA® Quadro RTX™ GPUs for ...
(Date:6/13/2019)... (PRWEB) , ... June 13, 2019 , ... ... , the first organization exclusively serving the end-to-end clinical and ancillary supply chain ... well as contract and medical research organizations, today announced it will sponsor a ...
(Date:6/6/2019)... (PRWEB) , ... June 05, 2019 , ... ... role as the exclusive financial advisor to Pathologists Bio-Medical Laboratories (PBM) on its ... a preeminent anatomic pathology platform that provides services to more than one dozen ...
Breaking Biology News(10 mins):